Results 171 to 180 of about 76,320 (330)

POTENTIATION BY NALOXONE OF PRESSOR REFLEXES [PDF]

open access: green, 1981
Jean‐Louis Montastruc   +2 more
openalex   +1 more source

Cannabinoid CB2 receptor‐mediated analgesia: mechanism‐based insights and therapeutic potential

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 21, Page 5090-5118, November 2025.
Agonists of the cannabinoid 2 (CB2) receptor have shown promise for the treatment of pain in a variety of animal models. However, despite current preclinical evidence supporting the use of CB2 agonists for pain, successful translation of findings from preclinical models to human patients is lacking.
Kelsey G. Guenther, Andrea G. Hohmann
wiley   +1 more source

Responding to reports of nitazene toxicity in Australia

open access: yes
Medical Journal of Australia, Volume 222, Issue 5, Page 216-219, March 2025.
Brendan Clifford   +5 more
wiley   +1 more source

Selatogrel: Potential to redefine timely anti‐platelet intervention

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 22, Page 5435-5452, November 2025.
Acute coronary syndrome (ACS) encompasses a number of heart diseases that cause a sudden decrease in coronary perfusion, precipitating cardiomyocyte necrosis or heightened risk thereof. This pathology is a major burden of cardiovascular disease.
Rudy N. Zalzal   +3 more
wiley   +1 more source

Naloxone Disparities in Adolescents: Access Laws Are Not Enough. [PDF]

open access: yesJ Pediatr Pharmacol Ther
Habermann S, Mazer-Amirshahi M, Toce MS.
europepmc   +1 more source

Home - About - Disclaimer - Privacy